HC Wainwright issued their FY2024 EPS estimates for Atara Biotherapeutics in a research note issued to investors on Wednesday, January 22nd. HC Wainwright analyst R. Burns forecasts that the ...
Cantor Fitzgerald boosted their FY2024 earnings per share (EPS) estimates for Cerus in a research note issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now forecasts that the ...
Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...